# OnCo record al8326 (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/al8326/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "al8326" ;
  schema:name "AL8326"@en ;
  schema:description "AL8326 is an experimental small-molecule drug from Advenchen Pharmaceuticals in phase 3 trials for small-cell lung cancer, non-small-cell lung cancer and renal cell carcinoma, with its target not yet stated publicly."@en ;
  schema:url <https://onco.cc/drugs/al8326/> ;
  schema:dateModified "2026-09-11"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/search?intr=AL8326>, <https://www.advenchen.com> ;
  onco:status "phase-3" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:modality "small molecule (structure undisclosed or not yet in PubChem)" ;
  onco:cancers <https://onco.cc/cancers/sclc/>, <https://onco.cc/cancers/nsclc/>, <https://onco.cc/cancers/rcc/> ;
  onco:companies <https://onco.cc/companies/advenchen-laboratories/> ;
  onco:trials <https://onco.cc/trials/nct06247605/> .